According to the largest pharmacists association in the USA, pharmacists overwhelmingly disagree with recent actions by some states to limit the dispensing of a well-established malaria drug as a possible treatment for COVID-19 disease.
COVID-19 is caused by the SARS-CoV-2 coronavirus, which was initially detected in China during 2019.
According to a new survey distributed on March 30, 2020, about 83 percent of independent pharmacists say they should be able to dispense a limited supply of malaria drugs, as long the patient has tested positive ….. and is under a doctor’s care.
The malaria drugs include the ingredients, such as hydroxychloroquine and chloroquine.
Douglas Hoey, CEO of the National Community Pharmacists Association (NCPA), said in a related press release, “This is a well-established drug that has been in use for decades for malaria as well as other conditions.”